Mini Review
Published on 07 Jan 2014
Chemical crosslinkers enhance detection of receptor interactomes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00171
- 16,978 views
- 16 citations
Type at least 3 characters
21,667 articles
Articles
Opinion
Published on 06 Jan 2014
Targeting neurosteroidogenesis as therapy for PTSD
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00166
- 8,512 views
- 27 citations
Hypothesis and Theory
Published on 03 Jan 2014
Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00168
- 42,541 views
- 113 citations
Review
Published on 02 Jan 2014
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00169
- 30,216 views
- 101 citations
Original Research
Published on 02 Jan 2014
Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00162
- 8,679 views
- 46 citations
Editorial
Published on 31 Dec 2013
Novel insights which may translate into treatments for irritable bowel syndrome
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00160
- 4,996 views
- 1 citation
Review
Published on 31 Dec 2013
Regional siderosis: a new challenge for iron chelation therapy
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00167
- 8,401 views
- 47 citations
Specialty Grand Challenge
Published on 30 Dec 2013
The grand challenges in obstetric and pediatric pharmacology
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00170
- 3,845 views
- 2 citations
Review
Published on 30 Dec 2013
The potential of polymeric micelles in the context of glioblastoma therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00157
- 10,158 views
- 32 citations
Original Research
Published on 30 Dec 2013
The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00165
- 6,718 views
- 25 citations
Original Research
Published on 27 Dec 2013
Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00164
- 6,341 views
- 1 citation
Review
Published on 27 Dec 2013
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00161
- 56,695 views
- 229 citations
Review
Published on 25 Dec 2013
Orexin receptor antagonists as therapeutic agents for insomnia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00163
- 22,072 views
- 49 citations
Review
Published on 18 Dec 2013
Genetic architecture of human fibrotic diseases: disease risk and disease progression
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00159
- 10,847 views
- 13 citations
Review
Published on 18 Dec 2013
Mind and body: how the health of the body impacts on neuropsychiatry
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00158
- 45,979 views
- 40 citations
Review
Published on 18 Dec 2013
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00156
- 34,964 views
- 215 citations